Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Safety of and Immune Response to an Adenoviral HIV-1 Vaccine in Healthy Adults

This study is ongoing, but not recruiting participants.
Information provided by (Responsible Party):
National Institute of Allergy and Infectious Diseases (NIAID) Identifier:
First received: February 18, 2008
Last updated: March 15, 2016
Last verified: March 2016